References
  1. Busse PJ, Christiansen SC. Hereditary Angioedema. N Engl J Med. 2020;382:1136-48.
  2. Leibovich-Nassi I, Reshef A. The Enigma of Prodromes in Hereditary Angioedema (HAE). Clin Rev Allergy Immunol. 2021;61(1):15-28.
  3. Leibovich-Nassi I, Golander H, Somech R, Har-Even D, Reshef A. New Instrument for the Evaluation of Prodromes and Attacks of Hereditary Angioedema (HAE-EPA). Clin Rev Allergy Immunol.2021;61(1):29-39.
  4. Leibovich-Nassi I, Reshef A, Somech R, Golander H. Prodromes as predictors of hereditary angioedema attacks. Allergy. 2022;77(4):1309-1312.
  5. Luyasu S, Charignon D, Ponard D, Drouet C, Ghannam A. Angioedema: Systemic activation process during prodromes. Ann Allergy Ast Immunol. 2018;121(2):248-249.
  6. Maurer M, Aberer W, Bouillet L et al. Hereditary angioedema attacks resolve faster and are shorter after early icatibant treatment.PLoS One. 2013;8(2):e53773.
  7. Kőhalmi KV, Veszeli N, Cervenak L, Varga L, Farkas H. A novel prophylaxis with C1-inhibitor concentrate in hereditary angioedema during erythema marginatum.Immunol Let. 2017;189:90-93.
  8. Babaoglu H, Atas N, Varan O, Satis H, Bilici Salman R, Guler A, et al. Frequency, characteristics, and clinical determinants of ’prodrome’ in familial Mediterranean fever patients. Scand J Rheumatol.2020;49(2):154-158.